Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations

Journal of Clinical Oncology

Volumn 30, Issue 32, 2012, Pages

  Wiesner, Thomas ^a,b   Fried, Isabella ^a   Ulz, Peter ^a   Stacher, Elvira ^a   Popper, Helmut ^a   Murali, Rajmohan ^b   Kutzner, Heinz ^c   Lax, Sigurd ^d   Smolle Jüttner, Freya ^a   Geigl, Jochen B ^a   Speicher, Michael R ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Dermatopathologie Friedrichshafen   (Germany)

^d RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CASE REPORT; CUTANEOUS MELANOMA; FAMILY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GERMLINE MUTATION; HISTOPATHOLOGY; HUMAN; MESOTHELIOMA; PERITONEUM MESOTHELIOMA; PLEURA MESOTHELIOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE BAP1;

ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MALE; MELANOMA; MESOTHELIOMA; MIDDLE AGED; PEDIGREE; PERITONEAL NEOPLASMS; PLEURAL NEOPLASMS; RISK FACTORS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84869417534     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.41.2965     Document Type: Article

References (19)

1. Harbour JW, Onken MD, Roberson ED, et al: Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330:1410-1413, 2010
2. Bott M, Brevet M, Taylor BS, et al: The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 43:668-672, 2011
3. Wiesner T, Obenauf AC, Murali R, et al: Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43:1018-1021, 2011
4. Testa JR, Cheung M, Pei J, et al: Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43:1022-1025, 2011
5. Abdel-Rahman MH, Pilarski R, Cebulla CM, et al: Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 48:856-859, 2011
6. Scheuermann JC, de Ayala Alonso AG, Oktaba K, et al: Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 465:243-247, 2010
7. Stokes MP, Rush J, Macneill J, et al: Profiling of UV-induced ATM/ATR signaling pathways. Proc Natl Acad Sci U S A 104:19855-19860, 2007
8. Matsuoka S, Ballif BA, Smogorzewska A, et al: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160-1166, 2007
9. Jensen DE, Proctor M, Marquis ST, et al: BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16:1097-1112, 1998
10. Goldstein AM: Germline BAP1 mutations and tumor susceptibility. Nat Genet 43:925-926, 2011
11. Yang H, Testa JR, Carbone M: Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Options Oncol 9:147-157, 2008
12. Bridda A, Padoan I, Mencarelli R, et al: Peritoneal mesothelioma: A review. MedGenMed 9:32, 2007
13. Carbone M, Emri S, Dogan AU, et al: A mesothelioma epidemic in Cappadocia: Scientific developments and unexpected social outcomes. Nat Rev Cancer 7:147-154, 2007
14. Roushdy-Hammady I, Siegel J, Emri S, et al: Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 357:444-445, 2001
15. Forbes SA, Bindal N, Bamford S, et al: COSMIC: Mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39:D945-D950, 2011
16. Wellcome Trust Sanger Institute: Catalogue of Somatic Mutations in Cancer. http://www.sanger.ac.uk/genetics/CGP/cosmic
17. Guo G, Gui Y, Gao S, et al: Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet 44:17-19, 2012
18. Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1- mutation carriers: Breast Cancer Linkage Consortium. Am J Hum Genet 56:265-271, 1995
19. Biesecker BB, Boehnke M, Calzone K, et al: Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 269:1970-1974, 1993